A fifty-three-year-old Bahraini male presented with a painless, slow growing mass in the left gluteal region. A work-up including pelvic MRI, chest CT scan and excisional biopsy was performed. The histology was low-grade fibromyxoid sarcoma (LGFMS). Immunohistochemistry tests confirmed the diagnosis. He received local radiotherapy as an alternative for re-resection.
The patient is maintained under close observation because the tumor has high tendency of local recurrence and possible pulmonary and liver metastases.
This specific distinctive entity of soft tissue sarcoma is yet to be reported in Bahrain; it has no clear protocol regarding the best follow-up recommendations.
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Low-grade fibromyxoid sarcoma (LGFMS) is considered distinctive entity of fibrosarcoma with a high potential of metastasis despite the benign histologic appearance; sometimes there is a long interval between tumor presentation and metastasis 1 . This rare tumor was first reported by Evans in 1987; therefore, it was called Evans tumor 2 . Its exact incidence is not well-known. These tumors usually occur in the proximal extremities and trunk 2, 3 . It can be found rarely in the retro-peritoneum, head or the chest wall 4 . The majority of cases occur in sub-fascial deep locations and affects typically young or middle-aged adults; but it has also been described in the pediatric population, where it tends to be smaller, superficial and easier to resect 4, 5 .
The aim of this presentation is to report a 53-year-old Bahraini male who developed a large mass in the left gluteal region. Imaging findings, surgical approach to the mass, distinctive immunohistochemistry and cytogenetic findings were highlighted. 
THE CASE
A fifty-three-year-old Bahraini male presented with slow growing painless two masses, one on the left gluteal region and the other on the lower left thigh posteriorly. Both masses were noted two years prior to the first visit. The left gluteal mass was painless at the start but began causing discomfort whilst sitting as it increased in size over the course of six months. There was no history of trauma; the mass was deep with no skin changes. His past history was only indicative of hypertension for which he was on regular therapy.
On examination, there was a large 10 cm well-marginated firm mass at the left gluteal region. There was another 3 cm soft mass on the lateral aspect of the lower one third of the left thigh, which appeared to be a lipoma. No enlarged inguinal lymph nodes were noted and also no abdominal organ or mass was palpable. Systemic examination was unremarkable.
Chest X-ray was normal and pelvic MRI using T1, T2 weighted TSE SPI and post contrast sequences showed 5x3.6x6 cm hypo-intense lesion inside the left gluteus maximus muscle, located posterior to the neck and proximal to femoral shaft, see figure 
Figure 4: Hyper and Hypo-Cellular Areas of Bland Spindle Cells in Myxoid Background
Immunohistochemistry revealed positive vimentin, CD34 was only focally positive; desmin, SMA, S100 were negative. The most likely diagnosis is low-grade fibromyxoid sarcoma (LGFMS). As there was doubt regarding the margins of the excision and the decision was against re-excision; the patient was given 33 sessions of radiotherapy.
Follow-up at the oncology clinic showed that the patient was asymptomatic apart from induration noted at the operative site with evident radiation changes. CT scan of the chest was normal but an upper abdominal ultrasound showed multiple hypo echoic lesions in the liver. Further work-up by MRI for the liver and the pelvis showed no residual lesion at the operative site and the changes in the liver were suggestive of fatty change with areas of fat sparing around gall bladder bed and focal areas at subscapular locations. These changes were considered to be benign. Ultrasound of the liver performed after one year has shown no changes and no signs of recurrence.
DISCUSSION
Low-grade fibromyxoid sarcoma (LGFMS) is a variant of fibrosarcoma with distinctive histopathological features. Immunohistochemical staining (IHC) is usually positive for vimentin while it is negative for a variety of antibodies such as desmin, keratin, S100 protein, epithelial membrane antigen (EMA), CD34 and CD31 6 . In our case, these results were negative and in consistence with expected diagnosis of LGFMS.
A similar entity is characterized by giant rosettes and the presence of areas of hyalinized acellular islands surrounded by oval and spindle cells has been named as 'Hyalinizing Spindle Cell Tumor with Giant Rosettes' (HSTGR) 7 . Reports have suggested that both entities are the same and reflect the neoplastic process 7 . Both entities shared the same pathologic mechanism: a specific identification of cytogenetics in the form of a balanced t(7;16) (q34;p11) translocation and fusion between FUS and CREB3L2 genes in both LGFMS and HSTGR were confirmed 8, 9 . This translocation seems to be specific for the diagnosis of these tumors; these tests are not available locally.
The differential diagnosis of LGFMS include myxomas, angiomyxomas myxoid liposarcoma or those with mixed myxoid and fibrous elements, such as neurofibroma, malignant peripheral sheath tumor and fibrous histiocytoma which can be differentiated by immunohistochemical stains (IHC) 10 .
It is difficult to diagnose LGFMS on fine needle aspiration or needle core biopsy; good excisional biopsy is advised.
LGFMS presents usually as long standing painless soft tissue mass as the case with our patient. The pre-biopsy duration can be up to 5 years in 15% of cases. On rare occasions it may present acutely such as acute respiratory distress and chest pain in case of chest wall LGFMS or as seizure activity in a patient with intracranial LGFMS.
Imaging findings of LGFMS are non-specific but certain CT and MRI findings have been described.
Evans in 1993 and Goodlad et al suggested that
LGFMS were paradoxically aggressive tumors 2, 3 . In the early series, the local recurrence was noted in 68%, metastases in 41% and death from disease in 18%. All of these cases were initially diagnosed and treated as benign lesions 11 .
In recent series, local recurrence was noted in 54%, metastases in 6% and death from disease in 2% 8 .
The presence of focal areas of high cellularity, nuclear enlargement, increased mitotic activity and necrosis is not considered of poor prognostic significance for recurrence or metastases 8 . The utilization of external beam radiation therapy (XRT) is recommended as an alternative for re-resection if the latter is difficult. XRT is likely to reduce the chances of local recurrences but it will not affect overall survival 2, 3, 12 .
Because of the high risk of late metastases, clinical follow-up and chest imaging are recommended for an extended period of time that is not yet well-defined. 
CONCLUSION

